• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us
    • Careers

Transparency Notification Tolefi SA Participatie Maatschappij Vlaanderen NV, SRIW SA / SA SOFIPOLE and Mayo Foundation for Medical Research and Education

July 12, 2013 By Celyad

Information on the total number of voting rights and shares (Article 15 of the Law of 2 August 2007)

Mont-Saint-Guibert, Belgium, 11 July, 2013 –The biotechnology company, Cardio3 BioSciences SA (Cardio3 BioSciences), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, today announces it has received a transparency declaration from Tolefi SA, Participatie Maatschappij Vlanderen (PMV) NV, Sofipole SA and Mayo Foundation for Medical Education and Research in accordance with the Belgian Law of 2nd May 2007 concerning disclosure of major holdings in issuers whose shares are admitted to trading on a Belgian regulated market.

As of today, the Company’s share capital amounts to EUR 21,412,720.43 and is represented by a total 6,125,567 shares (each share given one voting right).

Transparency notification from Tolefi SA

Cardio3 BioSciences received on July 11, 2013 notification of transparency arising from Tolefi SA having passed, on July 9, 2013, the 35% threshold.

  • Reason for notification: an ownership interest at the time of the IPO
  • Notification by a parent company or controlling person.
  • Person (s) holding (s) notification:
NameAddress
Tolefi SATOLEFI SA Drève of Carloo 27, 1180 Brussels
Serge GOBLET48 Golf Avenue, 1640 Rhode Saint Genese
Isabelle THOUMYRE48 Golf Avenue, 1640 Rhode Saint Genese

Tolefi SA is a family holding company 100% owned by Mr. Serge Goblet and his wife Isabelle Thoumyre. The company also holds 2,504 warrants giving 2504 voting rights

Transparency notification from Participatie Maatschappij Vlanderen NV

Cardio3 BioSciences received on July 10 2013, a transparency notification from Participatie Maatschappij Vlanderen NV, having passed, on July 5, 2013, the 5% threshold.

  • Reason for notification: an ownership interest at the time of the IPO
  • Notification by a parent company or controlling person.
  • Person (s) holding (s) notification
NameAddress
Participatiemaatschappij Vlaanderen NV (PMV NV)Oude Graanmarkt 63, 1000 Brussels
PMV-TINA Comm VAOude Graanmarkt 63, 1000 Brussels
Het Vlaams GewestMartelaarsplein 19, 1000 Brussels

Participatiemaatschappij Vlaanderen NV controls PMV-Tina Comm VA.

Transparency notification from SRIW SA/Sofipole SA

Cardio3 BioSciences, received on July 9 2013, a transparency notification from SRIW SA/Sofipole, having passed, on July 5, 2013, the 10% threshold.

  • Reason for notification: an ownership interest at the time of the IPO
  • Notification by a parent company or controlling person.
  • Person (s) holding (s) notification
NameAddress
S.R.I.W SAavenue Maurice Destenay 13, 4000 Liège
SOFIPOLE SAavenue Maurice Destenay 13, 4000 Liège

The Walloon Region owns 98.65% of SRIW SA, which owns 60% of shares in SOFIPOLE SA.

Transparency notification from Mayo Foundation for Medical Education and Research

Cardio3 BioSciences received July 9, 2013 a transparency notification from the Mayo Foundation for Medical Education and Research, having passed on July 5, 2013, the 5% threshold.

  • Reason for notification: an ownership interest at the time of the IPO
  • Notification by a parent company or controlling person.
  • Person (s) holding (s) notification
NameAddress
Mayo Foundation for Medical Education and Research 200 First Street SW, Rochester, MN 55906-001 (United States of America)

Mayo Foundation for Medical Education and Research is not a controlled entity.

Download press release(s)
Communiqué de presse
Press Release

Filed Under: Corporate, Non-regulated

Footer

  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use

Our website uses cookies including analytics cookies to help improve it by collecting statistics on how visitors use our website. By clicking on "I accept", you allow us to place these analytics cookies. We also use cookies that are necessary for the good functioning of our website. You can find out more information about the cookies we use by visiting our Cookie Policy. I acceptI refuseCookie Policy